In Brazil, Demarest advised on the antitrust clearing procedure. Biogen (Nasdaq:BIIB) has exercised its option to purchase additional shares of Samsung Bioepis Co., Ltd., a joint…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
